FDA NDC Directory · JSON-LD · Markdown

ciprofloxacin hydrochloride and hydrocortisone

NDC 0713-0851 · HUMAN PRESCRIPTION DRUG · SUSPENSION/ DROPS

Labeler / ManufacturerCosette Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA218273
Dosage form / routeSUSPENSION/ DROPS · AURICULAR (OTIC)
Active ingredientsCIPROFLOXACIN HYDROCHLORIDE (2 mg/mL)
HYDROCORTISONE (10 mg/mL)
Marketing started20251204
Package count1

External sources

Source: openFDA. Public-domain (CC0).